{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T17:37:57Z","timestamp":1792431477365,"version":"4.5.0"},"reference-count":243,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008990","name":"Zhejiang Province Science and Technology Department","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008990","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.phrs.2021.105682","type":"journal-article","created":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T14:24:46Z","timestamp":1621347886000},"page":"105682","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"special_numbering":"C","title":["Allopregnanolone in mood disorders: Mechanism and therapeutic development"],"prefix":"10.1016","volume":"169","author":[{"given":"Shiyi","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4069-3337","authenticated-orcid":false,"given":"Lijuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9973-7464","authenticated-orcid":false,"given":"Xiaoyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1383-4296","authenticated-orcid":false,"given":"Yiping","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2021.105682_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.comppsych.2019.152147","article-title":"The association of cognitive deficits with mental and physical Quality of Life in Major Depressive Disorder","volume":"97","author":"Knight","year":"2020","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.phrs.2021.105682_bib2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/16506073.2017.1304445","article-title":"Effect of treatments for depression on quality of life: a meta-analysis","volume":"46","author":"Hofmann","year":"2017","journal-title":"Cogn. Behav. Ther."},{"key":"10.1016\/j.phrs.2021.105682_bib3","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1080\/09658210344000189","article-title":"Recollection deficits in dysphoric mood: an effect of schematic models and executive mode?","volume":"12","author":"Ramponi","year":"2004","journal-title":"Memory"},{"key":"10.1016\/j.phrs.2021.105682_bib4","unstructured":"World Health Organization. Depression and other common mental disorders: global health estimates, 2017."},{"key":"10.1016\/j.phrs.2021.105682_bib5","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/978-981-32-9705-0_14","article-title":"Comorbid anxiety and depression: clinical and conceptual consideration and transdiagnostic treatment","volume":"1191","author":"Choi","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.phrs.2021.105682_bib6","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1017\/S0033291704002612","article-title":"Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D","volume":"34","author":"Fava","year":"2004","journal-title":"Psychol. Med."},{"key":"10.1016\/j.phrs.2021.105682_bib7","doi-asserted-by":"crossref","first-page":"341","DOI":"10.4088\/JCP.10m06176blu","article-title":"Comorbidity patterns of anxiety and depressive disorders in a large cohort study: the Netherlands study of depression and anxiety (NESDA)","volume":"34","author":"Lamers","year":"2011","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.phrs.2021.105682_bib8","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1176\/ajp.155.7.910","article-title":"Effects of antidepressant treatment on neuroactive steroids in major depression","volume":"155","author":"Romeo","year":"1998","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.phrs.2021.105682_bib9","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1073\/pnas.95.6.3239","article-title":"Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine orfluvoxamine","volume":"95","author":"Uzunova","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.phrs.2021.105682_bib10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3109\/15622970009150572","article-title":"Effects of fluoxetine, indomethacine and placebo on 3 alpha, 5 alpha tetrahydroprogesterone (THP) plasma levels in uncomplicated alcohol withdrawal","volume":"1","author":"Romeo","year":"2000","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2021.105682_bib11","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/sj.mp.4001782","article-title":"Influence of mirtazapine on plasma concentrations of neuroactive steroids in major depression and on 3alpha-hydroxysteroid dehydrogenase activity","volume":"11","author":"Schule","year":"2006","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.phrs.2021.105682_bib12","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/sj.npp.1300460","article-title":"Role of neuroactive steroid allopregnanolone in antipsychotic-like action of olanzapine in rodents","volume":"29","author":"Ugale","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.phrs.2021.105682_bib13","unstructured":"FDA approves first treatment for post-partum depression. \u3008https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-treatment-post-partum-depression\u3009, 2019. (Accessed 19 March 2019)."},{"key":"10.1016\/j.phrs.2021.105682_bib14","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s40265-019-01121-0","article-title":"Brexanolone: first global approval","volume":"79","author":"Scott","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.phrs.2021.105682_bib15","doi-asserted-by":"crossref","DOI":"10.1177\/2470547018818555","article-title":"Overview of the molecular steps in steroidogenesis of the GABAergic neurosteroids allopregnanolone and pregnanolone","volume":"2","author":"Liang","year":"2018","journal-title":"Chronic Stress"},{"key":"10.1016\/j.phrs.2021.105682_bib16","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/805830","article-title":"GABA metabolism and transport: effects on synaptic efficacy","volume":"2012","author":"Roth","year":"2012","journal-title":"Neural Plast."},{"key":"10.1016\/j.phrs.2021.105682_bib17","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/mp.2010.120","article-title":"The GABAergic deficit hypothesis of major depressive disorder","volume":"16","author":"Luscher","year":"2011","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.phrs.2021.105682_bib18","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1007\/s00429-012-0479-1","article-title":"Chronic stress alters inhibitory networks in the medial prefrontal cortex of adult mice","volume":"218","author":"Gilabert-Juan","year":"2013","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.phrs.2021.105682_bib19","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.biopsych.2016.03.2101","article-title":"Chronic stress increases prefrontal inhibition: a mechanism for stress-induced prefrontal dysfunction","volume":"80","author":"McKlveen","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2021.105682_bib20","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1001\/archpsyc.61.7.705","article-title":"Subtype-Specific alterations of \u03b3-Aminobutyric acid and glutamatein patients with major depression","volume":"61","author":"Sanacora","year":"2004","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.phrs.2021.105682_bib21","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1001\/archpsyc.64.2.193","article-title":"Reduced prefrontal glutamate\/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy","volume":"64","author":"Hasler","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.phrs.2021.105682_bib22","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00213-006-0313-7","article-title":"Preliminary evidence of reduced occipital GABA concentrations in puerperal women: a 1H-MRS study","volume":"186","author":"Epperson","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.phrs.2021.105682_bib23","doi-asserted-by":"crossref","first-page":"4918","DOI":"10.1097\/MD.0000000000004918","article-title":"GABA+ levels in postmenopausal women with mild-to-moderate depression: a preliminary study","volume":"95","author":"Wang","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.phrs.2021.105682_bib24","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/tp.2016.181","article-title":"Impaired GABA synthesis, uptake and release are associated with depression-like behaviors induced by chronic mild stress","volume":"6","author":"Ma","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.phrs.2021.105682_bib25","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.18758.1","article-title":"Brexanolone, a neurosteroid antidepressant, vindicates the GABAergic deficit hypothesis of depression and may foster resilience","volume":"8","author":"Luscher","year":"2019","journal-title":"F1000Res"},{"key":"10.1016\/j.phrs.2021.105682_bib26","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0165-6147(00)89058-6","article-title":"Neurosteroids and GABAA receptor function","volume":"16","author":"Lambert","year":"1995","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.phrs.2021.105682_bib27","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/nrn1703","article-title":"Neurosteroids: endogenous regulators of the GABA(A) receptor","volume":"6","author":"Belelli","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.phrs.2021.105682_bib28","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0091-3057(03)00133-3","article-title":"Anti-conflict-like actions of intralateral septal infusions of allopregnanolone in Wistar rats","volume":"75","author":"Molina-Hernandez","year":"2003","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.phrs.2021.105682_bib29","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1358\/mf.2008.30.9.1186076","article-title":"Possible GABAergic modulation in the protective effect of allopregnanolone on sleep deprivation-induced anxiety-like behavior and oxidative damage in mice","volume":"30","author":"Singh","year":"2008","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"10.1016\/j.phrs.2021.105682_bib30","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0014-2999(95)00311-8","article-title":"Flumazenil blocks the anxiolytic action of allopregnanolone","volume":"281","author":"Fernandez-Guasti","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2021.105682_bib31","doi-asserted-by":"crossref","first-page":"231","DOI":"10.4306\/pi.2010.7.4.231","article-title":"The roles of BDNF in the pathophysiology of major depression and in antidepressant treatment","volume":"7","author":"Lee","year":"2010","journal-title":"Psychiatry Investig."},{"key":"10.1016\/j.phrs.2021.105682_bib32","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/00207454.2018.1527328","article-title":"Direct and indirect evidences of BDNF and NGF as key modulators in depression: role of antidepressants treatment","volume":"129","author":"Mondal","year":"2019","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.phrs.2021.105682_bib33","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jpsychires.2009.11.014","article-title":"Increased stress reactivity is associated with cognitive deficits and decreased hippocampal brain-derived neurotrophic factor in a mouse model of affective disorders","volume":"44","author":"Knapman","year":"2010","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.phrs.2021.105682_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4137\/CPath.S12530","article-title":"Decreased mRNA and protein expression of BDNF, NGF, and their receptors in the hippocampus from suicide: an analysis in human postmortem brain","volume":"6","author":"Banerjee","year":"2013","journal-title":"Clin. Med. Insights Pathol."},{"key":"10.1016\/j.phrs.2021.105682_bib35","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/sj.mp.4002059","article-title":"Reduced overflow of BDNF from the brain is linked with suicide risk in depressive illness","volume":"12","author":"Dawood","year":"2007","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.phrs.2021.105682_bib36","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fendo.2011.00073","article-title":"Neurosteroids reduce social isolation-induced behavioral deficits: a proposed link with neurosteroid-mediated upregulation of BDNF expression","volume":"2","author":"Nin","year":"2011","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.phrs.2021.105682_bib37","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1210\/mend.15.10.0706","article-title":"Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity","volume":"15","author":"Rios","year":"2001","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.phrs.2021.105682_bib38","first-page":"29","article-title":"Role of proBDNF and BDNF in dendritic spine plasticity and depressive-like behaviors induced by an animal model of depression","volume":"2017","author":"Qiao","year":"1663","journal-title":"Brain Res."},{"key":"10.1016\/j.phrs.2021.105682_bib39","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neuroscience.2018.11.029","article-title":"Hemisphere-dependent changes in mRNA expression of GABAA receptor subunits and BDNF after intra-prefrontal cortex allopregnanolone infusion in rats","volume":"397","author":"Almeida","year":"2019","journal-title":"Neuroscience"},{"key":"10.1016\/j.phrs.2021.105682_bib40","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/cns.13432","article-title":"Allopregnanolone restores the tyrosine hydroxylase\u2010positive neurons and motor performance in a 6\u2013OHDA\u2010injected mouse model","volume":"26","author":"Chen","year":"2020","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.phrs.2021.105682_bib41","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.psyneuen.2007.09.002","article-title":"Neuroactive steroids modulate HPA axis activity and cerebral brain-derived neurotrophic factor (BDNF) protein levels in adult male rats","volume":"32","author":"Naert","year":"2007","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.phrs.2021.105682_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2020.112670","article-title":"Allopregnanolone induces antidepressant-like effects through BDNF-TrkB signaling independent from AMPA receptor activation in a rat learned helplessness model of depression","volume":"390","author":"Shirayama","year":"2020","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.phrs.2021.105682_bib43","doi-asserted-by":"crossref","first-page":"pyu033","DOI":"10.1093\/ijnp\/pyu033","article-title":"BDNF release is required for the behavioral actions of ketamine","volume":"18","author":"Lepack","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.phrs.2021.105682_bib44","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.biopsych.2017.06.017","article-title":"Activity-dependent brain-derived neurotrophic factor release is required for the rapid antidepressant actions of scopolamine","volume":"83","author":"Ghosal","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2021.105682_bib45","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.neuropharm.2016.09.011","article-title":"Fast-acting antidepressants rapidly stimulate ERK signaling and BDNF release in primary neuronal cultures","volume":"111","author":"Lepack","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2021.105682_bib46","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.14344.1","article-title":"Ketamine and rapid-acting antidepressants: a new era in the battle against depression and suicide","volume":"7","author":"Duman","year":"2018","journal-title":"F1000Res"},{"key":"10.1016\/j.phrs.2021.105682_bib47","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.euroneuro.2017.08.427","article-title":"Striatal dopamine D2\/3 receptor-mediated neurotransmission in major depression: implications for anhedonia, anxiety and treatment response","volume":"27","author":"Pecina","year":"2017","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.phrs.2021.105682_bib48","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nrn.2016.57","article-title":"Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression","volume":"17","author":"Grace","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.phrs.2021.105682_bib49","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejphar.2013.07.022","article-title":"Dopamine D(3) receptor as a new pharmacological target for the treatment of depression","volume":"719","author":"Leggio","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2021.105682_bib50","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/FBP.0b013e32833470a7","article-title":"Dopamine is involved in the antidepressant-like effect of allopregnanolone in the forced swimming test in female rats","volume":"21","author":"D\u2019Aquila","year":"2010","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.phrs.2021.105682_bib51","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1177\/026988119601000402","article-title":"Inhibition of basal and stress-induced dopamine release in the cerebral cortex and nucleus accumbens of freely moving rats by the neurosteroid allopregnanolone","volume":"10","author":"Motzo","year":"1996","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.phrs.2021.105682_bib52","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0006-8993(02)02290-4","article-title":"Depletion of cortical allopregnanolone potentiates stress-induced increase in cortical dopamine output","volume":"932","author":"Dazzi","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.phrs.2021.105682_bib53","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.neuropharm.2011.01.013","article-title":"Isolation rearing-induced reduction of brain 5\u03b1-reductase expression: relevance to dopaminergic impairments","volume":"60","author":"Bortolato","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2021.105682_bib54","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1016\/S0024-3205(01)01290-5","article-title":"Anxiolytic effect of Kami-Shoyo-San (TJ-24) in mice: possible mediation of neurosteroid synthesis","volume":"69","author":"Mizowaki","year":"2001","journal-title":"Life Sci."},{"key":"10.1016\/j.phrs.2021.105682_bib55","article-title":"Kami-shoyo-san improves ASD-like behaviors caused by decreasing allopregnanolone biosynthesis in an SKF mouse model of autism","volume":"14","author":"Guo","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2021.105682_bib56","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jep.2019.03.010","article-title":"Kami-shoyo-san ameliorates sociability deficits in ovariectomized mice, a putative female model of autism spectrum disorder, via facilitating dopamine D1 and GABAA receptor functions","volume":"236","author":"Guo","year":"2019","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phrs.2021.105682_bib57","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/sj.npp.1301261","article-title":"Inhibition of evoked glutamate release by neurosteroid allopregnanolone via inhibition of L-type calcium channels in rat medial prefrontal cortex","volume":"32","author":"Hu","year":"2007","journal-title":"Neuropsychopharmacology"},{"issue":"Suppl 2","key":"10.1016\/j.phrs.2021.105682_bib58","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2202-9-S2-S11","article-title":"Allopregnanolone-induced rise in intracellular calcium in embryonic hippocampal neurons parallels their proliferative potential","volume":"9","author":"Wang","year":"2008","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.phrs.2021.105682_bib59","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.biopsych.2006.03.026","article-title":"Decreased cerebrospinal fluid allopregnanolone levels in women with posttraumatic stress disorder","volume":"60","author":"Rasmusson","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2021.105682_bib60","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.psyneuen.2018.09.021","article-title":"Treatment of male rats with finasteride, an inhibitor of 5alpha-reductase enzyme, induces long-lasting effects on depressive-like behavior, hippocampal neurogenesis, neuroinflammation and gut microbiota composition","volume":"99","author":"Diviccaro","year":"2019","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.phrs.2021.105682_bib61","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1473-2165.2010.00533.x","article-title":"Finasteride-induced depression: new insights into possible pathomechanisms","volume":"9","author":"Romer","year":"2010","journal-title":"J. Cosmet. Dermatol."},{"key":"10.1016\/j.phrs.2021.105682_bib62","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1515\/HMBCI.2010.010","article-title":"The influence of low dose finasteride, a type II 5\u03b1-reductase inhibitor, on circulating neuroactive steroids","volume":"1","author":"Duskova","year":"2010","journal-title":"Horm. Mol. Biol. Clin. Investig."},{"key":"10.1016\/j.phrs.2021.105682_bib63","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.neuroscience.2008.04.062","article-title":"Neonatal finasteride induces anxiogenic-like profile and deteriorates passive avoidance in adulthood after intrahippocampal neurosteroid administration","volume":"154","author":"Martin-Garcia","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.phrs.2021.105682_bib64","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3758\/CABN.1.3.287","article-title":"Inhibiting progesterone metabolism in the hippocampus of rats in behavioral estrus decreases anxiolytic behaviors and enhances exploratory and antinociceptive behaviors","volume":"1","author":"Rhodes","year":"2001","journal-title":"Cogn. Affect. Behav. Neurosci."},{"key":"10.1016\/j.phrs.2021.105682_bib65","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.bbr.2019.03.006","article-title":"Repeated finasteride administration induces depression-Like behavior in adult male rats","volume":"365","author":"Sasibhushana","year":"2019","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.phrs.2021.105682_bib66","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.pbb.2007.05.017","article-title":"Inhibition of progesterone metabolism mimics the effect of progesterone withdrawal on forced swim test immobility","volume":"87","author":"Beckley","year":"2007","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.phrs.2021.105682_bib67","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1006\/hbeh.2002.1763","article-title":"Changes in progesterone metabolites in the hippocampus can modulate open field and forced swim test behavior of proestrous rats","volume":"41","author":"Frye","year":"2002","journal-title":"Horm. Behav."},{"key":"10.1016\/j.phrs.2021.105682_bib68","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.pbb.2004.03.024","article-title":"Hippocampal 3alpha,5alpha-THP may alter depressive behavior of pregnant and lactating rats","volume":"78","author":"Frye","year":"2004","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.phrs.2021.105682_bib69","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1055\/s-0030-1249095","article-title":"Finasteride treatment inhibits adult hippocampal neurogenesis in male mice","volume":"43","author":"Romer","year":"2010","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.phrs.2021.105682_bib70","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1111\/jsm.12269","article-title":"Neuroactive steroid levels are modified in cerebrospinal fluid and plasma of post-finasteride patients showing persistent sexual side effects and anxious\/depressive symptomatology","volume":"10","author":"Melcangi","year":"2013","journal-title":"J. Sex. Med."},{"key":"10.1016\/j.phrs.2021.105682_bib71","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1007\/s00213-014-3567-5","article-title":"5\u03b1-reductase type I expression is downregulated in the prefrontal cortex\/Brodmann\u2019s area 9 (BA9) of depressed patients","volume":"231","author":"Agis-Balboa","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.phrs.2021.105682_bib72","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.psyneuen.2010.11.004","article-title":"Progesterone receptor antagonist CDB-4124 increases depression-like behavior in mice without affecting locomotor ability","volume":"36","author":"Beckley","year":"2011","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.phrs.2021.105682_bib73","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1745-0179-4-3","article-title":"The link between neurosteroids and syndromic\/syndromal components of the mood spectrum disorders in women during the premenstrual phase","volume":"4","author":"Hardoy","year":"2008","journal-title":"Clin. Pract. Epidemiol. Ment. Health"},{"key":"10.1016\/j.phrs.2021.105682_bib74","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1023\/A:1026622704704","article-title":"Serum concentrations of some neuroactive steroids in women suffering from mixed anxiety-depressive disorder","volume":"25","author":"Bicikova","year":"2000","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.phrs.2021.105682_bib75","doi-asserted-by":"crossref","first-page":"5567","DOI":"10.1073\/pnas.0801853105","article-title":"Decreased corticolimbic allopregnanolone expression during social isolation enhances contextual fear: a model relevant for posttraumatic stress disorder","volume":"105","author":"Pibiri","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2021.105682_bib76","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1046\/j.1471-4159.2000.0750732.x","article-title":"Social isolation\u2010induced decreases in both the abundance of neuroactive steroids and GABAA receptor function in rat brain","volume":"75","author":"Serra","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.phrs.2021.105682_bib77","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.neuropharm.2012.08.012","article-title":"Allopregnanolone regulates neurogenesis and depressive\/anxiety-like behaviour in a social isolation rodent model of chronic stress","volume":"63","author":"Evans","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2021.105682_bib78","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1073\/pnas.051628598","article-title":"Brain 5\u03b1-dihydroprogesterone and allopregnanolone synthesis in a mouse model of protracted social isolation","volume":"98","author":"Dong","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2021.105682_bib79","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0163-7258(97)00004-1","article-title":"The olfactory bulbectomized rat as a model of depression: an update","volume":"74","author":"Kelly","year":"1997","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.phrs.2021.105682_bib80","doi-asserted-by":"crossref","first-page":"18736","DOI":"10.1073\/pnas.0709419104","article-title":"Down-regulation of neurosteroid biosynthesis in corticolimbic circuits mediates social isolation-induced behavior in mice","volume":"104","author":"Agis-Balboa","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2021.105682_bib81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-8993(03)02577-0","article-title":"Region-specific dysregulation of allopregnanolone brain content in the olfactory bulbectomized rat model of depression","volume":"976","author":"Uzunova","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.phrs.2021.105682_bib82","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0166-4328(99)00101-1","article-title":"The amygdala mediates the anxiolytic-like effect of the neurosteroid allopregnanolone in rat","volume":"106","author":"Akwa","year":"1999","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.phrs.2021.105682_bib83","first-page":"99","article-title":"The open field test for measuring locomotor activity and anxiety-like behavior","volume":"2019","author":"Kraeuter","year":"1916","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.phrs.2021.105682_bib84","first-page":"1088","article-title":"Elevated plus maze for mice","volume":"22","author":"Komada","year":"2008","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.phrs.2021.105682_bib85","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.bbr.2008.06.005","article-title":"Exploratory, anti-anxiety, social, and sexual behaviors of rats in behavioral estrus is attenuated with inhibition of 3alpha,5alpha-THP formation in the midbrain ventral tegmental area","volume":"193","author":"Frye","year":"2008","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.phrs.2021.105682_bib86","doi-asserted-by":"crossref","first-page":"5275","DOI":"10.1523\/JNEUROSCI.18-14-05275.1998","article-title":"Withdrawal from 3alpha-OH-5alpha-pregnan-20-one using a pseudopregnancy model alters the kinetics of hippocampal GABAA-gated current and increases the GABAA receptor alpha4 subunit in association with increased anxiety","volume":"18","author":"Smith","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2021.105682_bib87","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s00213-005-0100-x","article-title":"Inhibiting 5\u03b1-reductase in the amygdala attenuates antianxiety and antidepressive behavior of naturally receptive and hormone-primed ovariectomized rats","volume":"186","author":"Walf","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.phrs.2021.105682_bib88","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.physbeh.2009.05.014","article-title":"Effects of gestational allopregnanolone administration in rats bred for high affective behavior","volume":"99","author":"Zimmerberg","year":"2010","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.phrs.2021.105682_bib89","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ijdevneu.2017.02.001","article-title":"Increased anxiety-like phenotype in female guinea pigs following reduced neurosteroid exposure in utero","volume":"58","author":"Cumberland","year":"2017","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.phrs.2021.105682_bib90","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1017\/S2040174415000069","article-title":"Preterm birth affects GABAA receptor subunit mRNA levels during the foetal-to-neonatal transition in guinea pigs","volume":"6","author":"Shaw","year":"2015","journal-title":"J. Dev. Orig. Health Dis."},{"key":"10.1016\/j.phrs.2021.105682_bib91","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1038\/sj.npp.1300952","article-title":"Neuroactive steroids are altered in schizophrenia and bipolar disorder: relevance to pathophysiology and therapeutics","volume":"31","author":"Marx","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.phrs.2021.105682_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.ynstr.2019.100203","article-title":"Pleiotropic actions of allopregnanolone underlie therapeutic benefits in stress-related disease","volume":"12","author":"Boero","year":"2020","journal-title":"Neurobiol. Stress"},{"key":"10.1016\/j.phrs.2021.105682_bib93","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.physbeh.2018.06.014","article-title":"The effect of intracerebroventricular allopregnanolone on depressive-like behaviors of rats selectively bred for high and low immobility in the forced swim test","volume":"194","author":"Almeida","year":"2018","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.phrs.2021.105682_bib94","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.pnpbp.2004.08.006","article-title":"Synergistic interaction between ketoconazole and several antidepressant drugs with allopregnanolone treatments in ovariectomized Wistar rats forced to swim","volume":"28","author":"Molina-Hernandez","year":"2004","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2021.105682_bib95","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0091-3057(00)00300-2","article-title":"Antidepressant-like effect of the neurosteroid 3alpha-hydroxy-5alpha-pregnan-20-one in mice forced swim test","volume":"67","author":"Khisti","year":"2000","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.phrs.2021.105682_bib96","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0006-8993(00)02373-8","article-title":"Serotonergic agents modulate antidepressant-like effect of the neurosteroid 3\u03b1-hydroxy-5\u03b1-pregnan-20-one in mice","volume":"865","author":"Khisti","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.phrs.2021.105682_bib97","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.pbb.2004.11.017","article-title":"Antidepressant-like actions of intra-accumbens infusions of allopregnanolone in ovariectomized Wistar rats","volume":"80","author":"Molina-Hernandez","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.phrs.2021.105682_bib98","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.pbb.2012.09.002","article-title":"The effect of intra-nucleus accumbens administration of allopregnanolone on \u03b4 and \u03b32 GABAA receptor subunit mRNA expression in the hippocampus and on depressive-like and grooming behaviors in rats","volume":"103","author":"Nin","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.phrs.2021.105682_bib99","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1177\/0269881106064203","article-title":"Allopregnanolone reduces immobility in the forced swimming test and increases the firing rate of lateral septal neurons through actions on the GABAA receptor in the rat","volume":"21","author":"Rodriguez-Landa","year":"2007","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.phrs.2021.105682_bib100","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1017\/S146114570500595X","article-title":"Allopregnanolone and ganaxolone increase the firing activity of dorsal raphe nucleus serotonergic neurons in female rats","volume":"9","author":"Robichaud","year":"2006","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.phrs.2021.105682_bib101","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2826.2005.01292.x","article-title":"Oestrogen and testosterone modulate the firing activity of dorsal raphe nucleus serotonergic neurones in both male and female rats","volume":"17","author":"Robichaud","year":"2005","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.phrs.2021.105682_bib102","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1677\/joe.0.1820011","article-title":"Modulation of the firing activity of female dorsal raphe nucleus serotonergic neurons by neuroactive steroids","volume":"182","author":"Robichaud","year":"2004","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.phrs.2021.105682_bib103","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0306-4522(00)00442-5","article-title":"GABAA receptors: immunocytochemical distribution of 13 subunits in the adult rat brain","volume":"101","author":"Pirker","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.phrs.2021.105682_bib104","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/hipo.20824","article-title":"Infusions of allopregnanolone into the hippocampus and amygdala, but not into the nucleus accumbens and medial prefrontal cortex, produce antidepressant effects on the learned helplessness rats","volume":"21","author":"Shirayama","year":"2011","journal-title":"Hippocampus"},{"key":"10.1016\/j.phrs.2021.105682_bib105","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/FBP.0b013e328331b9f2","article-title":"Allopregnanolone microinjected into the lateral septum or dorsal hippocampus reduces immobility in the forced swim test: participation of the GABAA receptor","volume":"20","author":"Rodriguez-Landa","year":"2009","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.phrs.2021.105682_bib106","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.pbb.2004.11.017","article-title":"Antidepressant-like actions of intra-accumbens infusions of allopregnanolone in ovariectomized Wistar rats","volume":"80","author":"Molina-Hernandez","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.phrs.2021.105682_bib107","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.pbb.2012.09.002","article-title":"The effect of intra-nucleus accumbens administration of allopregnanolone on \u03b4 and \u03b32 GABAA receptor subunit mRNA expression in the hippocampus and on depressive-like and grooming behaviors in rats","volume":"103","author":"Nin","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.phrs.2021.105682_bib108","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.neuropharm.2010.10.011","article-title":"S-norfluoxetine microinfused into the basolateral amygdala increases allopregnanolone levels and reduces aggression in socially isolated mice","volume":"60","author":"Nelson","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2021.105682_bib109","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1073\/pnas.0409643102","article-title":"Changes in brain testosterone and allopregnanolone biosynthesis elicit aggressive behavior","volume":"102","author":"Pinna","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2021.105682_bib110","doi-asserted-by":"crossref","first-page":"6222","DOI":"10.1073\/pnas.0401479101","article-title":"Fluoxetine and norfluoxetine stereospecifically facilitate pentobarbital sedation by increasing neurosteroids","volume":"101","author":"Pinna","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2021.105682_bib111","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1073\/pnas.0337642100","article-title":"In socially isolated mice, the reversal of brain allopregnanolone down-regulation mediates the anti-aggressive action of fluoxetine","volume":"100","author":"Pinna","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2021.105682_bib112","doi-asserted-by":"crossref","first-page":"12599","DOI":"10.1073\/pnas.93.22.12599","article-title":"Fluoxetine-elicited changes in brain neurosteroid content measured by negative ion mass fragmentography","volume":"93","author":"Uzunov","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2021.105682_bib113","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejphar.2003.12.002","article-title":"Chronic antidepressants reverse cerebrocortical allopregnanolone decline in the olfactory-bulbectomized rat","volume":"486","author":"Uzunova","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2021.105682_bib114","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.euroneuro.2014.11.017","article-title":"Elevation of brain allopregnanolone rather than 5-HT release by short term, low dose fluoxetine treatment prevents the estrous cycle-linked increase in stress sensitivity in female rats","volume":"25","author":"Devall","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.phrs.2021.105682_bib115","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1177\/0269881119841833","article-title":"Short-term, low-dose fluoxetine prevents oestrous cycle-linked increase in anxiety-like behaviour in female rats","volume":"33","author":"Figueiredo","year":"2019","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.phrs.2021.105682_bib116","doi-asserted-by":"crossref","first-page":"5870","DOI":"10.1111\/bph.12891","article-title":"Fluoxetine elevates allopregnanolone in female rat brain but inhibits a steroid microsomal dehydrogenase rather than activating an aldo-keto reductase","volume":"171","author":"Fry","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2021.105682_bib117","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.pbb.2006.07.032","article-title":"Olanzapine and fluoxetine administration and coadministration increase rat hippocampal pregnenolone, allopregnanolone and peripheral deoxycorticosterone: implications for therapeutic actions","volume":"84","author":"Marx","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.phrs.2021.105682_bib118","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11011-017-0127-9","article-title":"The anxiolytic-like effects of puerarin are associated with the changes of monoaminergic neurotransmitters and biosynthesis of allopregnanolone in the brain","volume":"33","author":"Qiu","year":"2018","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.phrs.2021.105682_bib119","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0924-977X(03)00015-4","article-title":"Brain neurosteroid changes after paroxetine administration in mice","volume":"13","author":"Nechmad","year":"2003","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.phrs.2021.105682_bib120","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/026988110201600203","article-title":"Prevention of the stress-induced increase in the concentration of neuroactive steroids in rat brain by long-term administration of mirtazapine but not of fluoxetine","volume":"16","author":"Serra","year":"2002","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.phrs.2021.105682_bib121","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.npp.1300015","article-title":"Olanzapine and clozapine increase the GABAergic neuroactive steroid allopregnanolone in rodents","volume":"28","author":"Marx","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.phrs.2021.105682_bib122","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0006-3223(99)00305-4","article-title":"Olanzapine increases allopregnanolone in the rat cerebral cortex","volume":"47","author":"Marx","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2021.105682_bib123","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0893-133X(01)00254-8","article-title":"Clozapine, but not haloperidol, increases brain concentrations of neuroactive steroids in the rat","volume":"25","author":"Barbaccia","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.phrs.2021.105682_bib124","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1016\/S0028-3908(00)00086-1","article-title":"Steroidogenesis in rat brain induced by short- and long-term administration of carbamazepine","volume":"39","author":"Serra","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2021.105682_bib125","first-page":"235","article-title":"Efficacy of carbamazepine as an antidepressant in chronic resistant depressives","volume":"83","author":"Prasad","year":"1985","journal-title":"J. Indian Med. Assoc."},{"key":"10.1016\/j.phrs.2021.105682_bib126","first-page":"363","article-title":"Anti-depressive therapy with carbamazepine (Finlepsin)","volume":"133","author":"Wunderlich","year":"1983","journal-title":"Schweiz. Arch. Neurol. Neurochir. Psychiatr."},{"key":"10.1016\/j.phrs.2021.105682_bib127","doi-asserted-by":"crossref","DOI":"10.1002\/hup.2576","article-title":"Open-label, proof-of-concept study of brexanolone in the treatment of severe postpartum depression","volume":"32","author":"Kanes","year":"2017","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.phrs.2021.105682_bib128","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0140-6736(17)31264-3","article-title":"Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial","volume":"390","author":"Kanes","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2021.105682_bib129","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0140-6736(18)31551-4","article-title":"Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials","volume":"392","author":"Meltzer-Brody","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2021.105682_bib130","doi-asserted-by":"crossref","first-page":"13512","DOI":"10.1073\/pnas.96.23.13512","article-title":"Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes","volume":"96","author":"Griffin","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2021.105682_bib131","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1111\/j.1530-0277.2009.01047.x","article-title":"Selected line difference in the effects of ethanol dependence and withdrawal on allopregnanolone levels and 5alpha-reductase enzyme activity and expression","volume":"33","author":"Tanchuck","year":"2009","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.phrs.2021.105682_bib132","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.alcohol.2011.08.002","article-title":"Localization of brain 5\u03b1-reductase messenger RNA in mice selectively bred for high chronic alcohol withdrawal severity","volume":"45","author":"Roselli","year":"2011","journal-title":"Alcohol"},{"key":"10.1016\/j.phrs.2021.105682_bib133","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2005.08.012","article-title":"To combine or not to combine? A literature review of antidepressant combination therapy","volume":"89","author":"Dodd","year":"2005","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.phrs.2021.105682_bib134","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.pbb.2009.06.015","article-title":"Olanzapine plus 17-beta estradiol produce antidepressant-like actions in rats forced to swim","volume":"93","author":"Molina-Hernandez","year":"2009","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.phrs.2021.105682_bib135","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/sj.npp.1300821","article-title":"Participation of the 5-HT1A receptor in the antidepressant-like effect of estrogens in the forced swimming test","volume":"31","author":"Estrada-Camarena","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.phrs.2021.105682_bib136","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF02245251","article-title":"Comparative behavioral characterization of the neuroactive steroids 3 alpha-OH,5 alpha-pregnan-20-one and 3 alpha-OH,5 beta-pregnan-20-one in rodents","volume":"118","author":"Wieland","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.phrs.2021.105682_bib137","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0091-3057(97)00339-0","article-title":"Behaviorally selective effects of neuroactive steroids on plus-maze anxiety in mice","volume":"59","author":"Rodgers","year":"1998","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.phrs.2021.105682_bib138","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0006-8993(91)90761-J","article-title":"Anxiolytic effects of 3 alpha-hydroxy-5 alpha[beta]-pregnan-20-one: endogenous metabolites of progesterone that are active at the GABAA receptor","volume":"561","author":"Bitran","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/j.phrs.2021.105682_bib139","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0006-8993(95)00254-N","article-title":"Anti-anxiety effects of progesterone and some of its reduced metabolites: an evaluation using the burying behavior test","volume":"680","author":"Picazo","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.phrs.2021.105682_bib140","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0006-8993(96)01447-3","article-title":"Differential anxiolytic effects of neurosteroids in the mirrored chamber behavior test in mice","volume":"752","author":"Reddy","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.phrs.2021.105682_bib141","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0006-8993(91)91658-N","article-title":"Anxiolytic activity of the progesterone metabolite 5 alpha-pregnan-3 alpha-o1-20-one","volume":"565","author":"Wieland","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/j.phrs.2021.105682_bib142","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0022-3565(24)36770-9","article-title":"Ultrasonic vocalizations in rat pups: modulation at the gamma-aminobutyric acid A receptor complex and the neurosteroid recognition site","volume":"282","author":"Vivian","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phrs.2021.105682_bib143","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/0091-3057(94)90181-3","article-title":"Reduction of rat pup ultrasonic vocalizations by the neuroactive steroid allopregnanolone","volume":"47","author":"Zimmerberg","year":"1994","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.phrs.2021.105682_bib144","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2826.1995.tb00744.x","article-title":"Anxiolytic effect of progesterone is mediated by the neurosteroid allopregnanolone at brain GABAA receptors","volume":"7","author":"Bitran","year":"1995","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.phrs.2021.105682_bib145","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0091-3057(93)90260-Z","article-title":"Anxiolytic effect of progesterone is associated with increases in cortical allopregnanolone and GABAA receptor function","volume":"45","author":"Bitran","year":"1993","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.phrs.2021.105682_bib146","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.psyneuen.2009.08.020","article-title":"Alterations in neonatal neurosteroids affect exploration during adolescence and prepulse inhibition in adulthood","volume":"35","author":"Darbra","year":"2010","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.phrs.2021.105682_bib147","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0166-4328(99)00101-1","article-title":"The amygdala mediates the anxiolytic-like effect of the neurosteroid allopregnanolone in rat","volume":"106","author":"Akwa","year":"1999","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.phrs.2021.105682_bib148","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/FBP.0b013e3282d28f6f","article-title":"The anxiolytic-like effects of allopregnanolone vary as a function of intracerebral microinfusion site: the amygdala, medial prefrontal cortex, or hippocampus","volume":"18","author":"Engin","year":"2007","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.phrs.2021.105682_bib149","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.bbr.2011.03.058","article-title":"Neurosteroids infusion into the CA1 hippocampal region on exploration, anxiety-like behaviour and aversive learning","volume":"222","author":"Modol","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.phrs.2021.105682_bib150","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0006-8993(99)02150-2","article-title":"Anxiolytic effects of the neuroactive steroid pregnanolone (3 alpha-OH-5 beta-pregnan-20-one) after microinjection in the dorsal hippocampus and lateral septum","volume":"850","author":"Bitran","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.phrs.2021.105682_bib151","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s002130000471","article-title":"Activation of peripheral mitochondrial benzodiazepine receptors in the hippocampus stimulates allopregnanolone synthesis and produces anxiolytic-like effects in the rat","volume":"151","author":"Bitran","year":"2000","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.phrs.2021.105682_bib152","first-page":"136","article-title":"Effects and mechanisms of 3\u03b1,5\u03b1,-THP on emotion, motivation, and reward functions involving pregnane xenobiotic receptor","volume":"5","author":"Frye","year":"2011","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.phrs.2021.105682_bib153","first-page":"e188","article-title":"Progesterone turnover to its 5\u03b1-reduced metabolites in the ventral tegmental area of the midbrain is essential for initiating social and affective behavior and progesterone metabolism in female rats","volume":"34","author":"Frye","year":"2011","journal-title":"J. Endocrinol. Investig."},{"key":"10.1016\/j.phrs.2021.105682_bib154","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.bbr.2007.08.031","article-title":"Infusions of 3alpha,5alpha-THP to the VTA enhance exploratory, anti-anxiety, social, and sexual behavior and increase levels of 3alpha,5alpha-THP in midbrain, hippocampus, diencephalon, and cortex of female rats","volume":"187","author":"Frye","year":"2008","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.phrs.2021.105682_bib155","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/j.1365-2826.2006.01494.x","volume":"18","author":"Frye","year":"2006","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.phrs.2021.105682_bib156","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.biopsych.2012.12.008","article-title":"Allopregnanolone elevations following pregnenolone administration are associated with enhanced activation of emotion regulation neurocircuits","volume":"73","author":"Sripada","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2021.105682_bib157","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1002\/hbm.22399","article-title":"The neurosteroids allopregnanolone and dehydroepiandrosterone modulate resting-state amygdala connectivity","volume":"35","author":"Sripada","year":"2014","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.phrs.2021.105682_bib158","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.psychres.2018.12.034","article-title":"The anxiolytic-like effects of ginsenoside Rg2 on an animal model of PTSD","volume":"279","author":"Gao","year":"2018","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.phrs.2021.105682_bib159","doi-asserted-by":"crossref","first-page":"7741","DOI":"10.1038\/s41598-018-26146-5","article-title":"The anxiolytic-like effects of ginsenoside Rg3 on chronic unpredictable stress in rats","volume":"8","author":"Xu","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2021.105682_bib160","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s11418-015-0943-3","article-title":"Ginsenoside Rb1 rescues anxiety-like responses in a rat model of post-traumatic stress disorder","volume":"70","author":"Lee","year":"2016","journal-title":"J. Nat. Med."},{"key":"10.1016\/j.phrs.2021.105682_bib161","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jep.2015.12.029","article-title":"Antidepressant-like effects of albiflorin extracted from Radix paeoniae Alba","volume":"179","author":"Wang","year":"2016","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phrs.2021.105682_bib162","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.neulet.2016.09.001","article-title":"Antidepressant-like effects of the radix bupleuri and eadix paeoniae alba drug pair","volume":"633","author":"Wang","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.phrs.2021.105682_bib163","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jep.2016.12.028","article-title":"Anti-PTSD-like effects of albiflorin extracted from Radix paeoniae Alba","volume":"198","author":"Qiu","year":"2017","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phrs.2021.105682_bib164","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0091-3057(01)00730-4","article-title":"The effect of Morinda officinalis How, a Chinese traditional medicinal plant, on the DRL 72-s schedule in rats and the forced swimming test in mice","volume":"72","author":"Zhang","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.phrs.2021.105682_bib165","first-page":"1084","article-title":"Antistress effect of oligosaccharides extracted from Morinda officinalis in mice and rats","volume":"22","author":"Li","year":"2001","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.phrs.2021.105682_bib166","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s11011-016-9853-7","article-title":"The inulin-type oligosaccharides extract from morinda officinalis, a traditional Chinese herb, ameliorated behavioral deficits in an animal model of post-traumatic stress disorder","volume":"31","author":"Qiu","year":"2016","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.phrs.2021.105682_bib167","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.steroids.2015.05.010","article-title":"Resveratrol ameliorates depressive-like behavior in repeated corticosterone-induced depression in mice","volume":"101","author":"Ali","year":"2015","journal-title":"Steroids"},{"key":"10.1016\/j.phrs.2021.105682_bib168","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s11011-016-9927-6","article-title":"Neurobehavioural evaluation of resveratrol in murine models of anxiety and schizophrenia","volume":"32","author":"Magaji","year":"2017","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.phrs.2021.105682_bib169","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1177\/0269881120914221","article-title":"trans-Resveratrol ameliorates anxiety-like behaviors and neuropathic pain in mouse model of post-traumatic stress disorder","volume":"34","author":"Yuan","year":"2020","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.phrs.2021.105682_bib170","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.neuropharm.2017.12.035","article-title":"trans-Resveratrol ameliorates anxiety-like behaviors and fear memory deficits in a rat model of post-traumatic stress disorder","volume":"133","author":"Li","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2021.105682_bib171","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.pbb.2017.09.004","article-title":"Resveratrol ameliorated the behavioral deficits in a mouse model of post-traumatic stress disorder","volume":"161","author":"Zhang","year":"2017","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.phrs.2021.105682_bib172","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.3390\/molecules24244569","article-title":"Effects of puerarin on the ovariectomy-Induced depressive-Like behavior in ICR mice and its possible mechanism of action","volume":"24","author":"Tantipongpiradet","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.phrs.2021.105682_bib173","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1007\/s12035-016-9870-x","article-title":"Plant natural product puerarin ameliorates depressive behaviors and chronic pain in mice with spared nerve injury (SNI)","volume":"54","author":"Zhao","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.phrs.2021.105682_bib174","doi-asserted-by":"crossref","first-page":"6266","DOI":"10.1038\/s41598-017-06552-x","article-title":"Puerarin ameliorated the behavioral deficits induced by chronic stress in rats","volume":"7","author":"Qiu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2021.105682_bib175","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108978","article-title":"The anxiolytic-like effects of puerarin on an animal model of PTSD","volume":"115","author":"Su","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.phrs.2021.105682_bib176","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1358\/mf.2002.24.1.677123","article-title":"Behavioral effect of herbal glycoside in the forced swimming test","volume":"24","author":"Masuda","year":"2002","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"10.1016\/j.phrs.2021.105682_bib177","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jpsychires.2005.06.002","article-title":"Adjunctive herbal medicine with carbamazepine for bipolar disorders: a double-blind, randomized, placebo-controlled study","volume":"41","author":"Zhang","year":"2007","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.phrs.2021.105682_bib178","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.jpsychires.2006.08.002","article-title":"The beneficial effects of the herbal medicine Free and Easy Wanderer Plus (FEWP) for mood disorders: double-blind, placebo-controlled studies","volume":"41","author":"Zhang","year":"2007","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.phrs.2021.105682_bib179","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.pnpbp.2009.07.031","article-title":"Free and Easy Wanderer Plus (FEWP), a polyherbal preparation, ameliorates PTSD-like behavior and cognitive impairments in stressed rats","volume":"33","author":"Wang","year":"2009","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2021.105682_bib180","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.neulet.2015.06.055","article-title":"Free and Easy Wanderer Plus (FEWP) improves behavioral deficits in an animal model of post-traumatic stress disorder by stimulating allopregnanolone biosynthesis","volume":"602","author":"Qiu","year":"2015","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.phrs.2021.105682_bib181","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3389\/fpsyt.2017.00248","article-title":"Economic and health predictors of national postpartum depression prevalence: a systematic review, meta-analysis, and meta-regression of 291 studies from 56 countries","volume":"8","author":"Hahn-Holbrook","year":"2017","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.phrs.2021.105682_bib182","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s40263-019-00605-7","article-title":"Pharmacotherapy of postpartum depression: current approaches and novel drug development","volume":"33","author":"Frieder","year":"2019","journal-title":"CNS Drugs"},{"key":"10.1016\/j.phrs.2021.105682_bib183","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.yfrne.2018.12.001","article-title":"Pathophysiological mechanisms implicated in postpartum depression","volume":"52","author":"Payne","year":"2019","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.phrs.2021.105682_bib184","doi-asserted-by":"crossref","DOI":"10.1016\/j.ynstr.2020.100212","article-title":"Allopregnanolone in postpartum depression: role in pathophysiology and treatment","volume":"12","author":"Meltzer-Brody","year":"2020","journal-title":"Neurobiol. Stress"},{"key":"10.1016\/j.phrs.2021.105682_bib185","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/s41386-018-0242-2","article-title":"Resting-state functional connectivity, cortical GABA, and neuroactive steroids in peripartum and peripartum depressed women: a functional magnetic resonance imaging and spectroscopy study","volume":"44","author":"Deligiannidis","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.phrs.2021.105682_bib186","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.psyneuen.2016.05.010","article-title":"Peripartum neuroactive steroid and \u03b3-aminobutyric acid profiles in women at-risk for postpartum depression","volume":"70","author":"Deligiannidis","year":"2016","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.phrs.2021.105682_bib187","first-page":"77","article-title":"Serum allopregnanolone in women with postpartum \u201cblues\u201d","volume":"97","author":"Nappi","year":"2001","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.phrs.2021.105682_bib188","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1176\/appi.ajp.157.6.924","article-title":"Effects of gonadal steroids in women with a history of postpartum depression","volume":"157","author":"Bloch","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.phrs.2021.105682_bib189","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.steroids.2014.12.007","article-title":"Quantification of neurosteroids during pregnancy using selective ion monitoring mass spectrometry","volume":"95","author":"Pennell","year":"2015","journal-title":"Steroids"},{"key":"10.1016\/j.phrs.2021.105682_bib190","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.psyneuen.2005.11.006","article-title":"Observational study on the stability of the psychological status during normal pregnancy and increased blood levels of neuroactive steroids with GABA-A receptor agonist activity","volume":"31","author":"Paoletti","year":"2006","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.phrs.2021.105682_bib191","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1080\/09513590500361747","article-title":"3alpha-reduced neuroactive steroids and their precursors during pregnancy and the postpartum period","volume":"21","author":"Evans","year":"2005","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.phrs.2021.105682_bib192","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1210\/jcem.85.7.6675","article-title":"Serum allopregnanolone levels in pregnant women: changes during pregnancy, at delivery, and in hypertensive patients","volume":"85","author":"Luisi","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.phrs.2021.105682_bib193","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000358838","article-title":"Low serum allopregnanolone is associated with symptoms of depression in late pregnancy","volume":"69","author":"Hellgren","year":"2014","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.phrs.2021.105682_bib194","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.psyneuen.2017.02.012","article-title":"Lower allopregnanolone during pregnancy predicts postpartum depression: an exploratory study","volume":"79","author":"Osborne","year":"2017","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.phrs.2021.105682_bib195","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3389\/fpsyg.2019.01033","article-title":"The role of allopregnanolone in pregnancy in predicting postpartum anxiety symptoms","volume":"10","author":"Osborne","year":"2019","journal-title":"Front. Psychol."},{"key":"10.1016\/j.phrs.2021.105682_bib196","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1523\/JNEUROSCI.4945-06.2007","article-title":"Neurosteroid synthesis-mediated regulation of GABAA receptors: relevance to the ovarian cycle and stress","volume":"27","author":"Maguire","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2021.105682_bib197","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nn1469","article-title":"Ovarian cycle-linked changes in GABA(A) receptors mediating tonic inhibition alter seizure susceptibility and anxiety","volume":"8","author":"Maguire","year":"2005","journal-title":"Nat. Neurosci."},{"issue":"Suppl 1","key":"10.1016\/j.phrs.2021.105682_bib198","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1016\/j.psyneuen.2009.06.013","article-title":"Plasticity and function of extrasynaptic GABAA receptors during pregnancy and after delivery","volume":"34","author":"Mostallino","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.phrs.2021.105682_bib199","article-title":"Plasticity of GABAA receptors during pregnancy and postpartum period: from gene to function","volume":"2015","author":"Licher","year":"2015","journal-title":"Neural Plast."},{"key":"10.1016\/j.phrs.2021.105682_bib200","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.neuron.2008.06.019","article-title":"GABA(A)R plasticity during pregnancy: relevance to postpartum depression","volume":"59","author":"Maguire","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.phrs.2021.105682_bib201","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.4088\/JCP.15r10174","article-title":"The perinatal depression treatment cascade: baby steps toward improving outcomes","volume":"77","author":"Cox","year":"2016","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.phrs.2021.105682_bib202","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1056\/NEJMoa052963","article-title":"STAR*D Study Team, Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression","volume":"354","author":"Rush","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2021.105682_bib203","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","article-title":"STAR*D Study Team, Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice","volume":"163","author":"Trivedi","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.phrs.2021.105682_bib204","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","article-title":"Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis","volume":"391","author":"Cipriani","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2021.105682_bib205","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.psychres.2019.07.006","article-title":"Brexanolone for postpartum depression: a meta-analysis of randomized controlled studies","volume":"279","author":"Zheng","year":"2019","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.phrs.2021.105682_bib206","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1017\/S0033291716000064","article-title":"Single-dose infusion ketamine and non-ketamine N-methyl-D-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories","volume":"46","author":"Kishimoto","year":"2016","journal-title":"Psychol. Med."},{"key":"10.1016\/j.phrs.2021.105682_bib207","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s40263-019-00672-w","article-title":"Using matching-adjusted indirect comparisons and network meta-analyses to compare efficacy of brexanolone injection with selective serotonin reuptake inhibitors for treating postpartum depression","volume":"33","author":"Cooper","year":"2019","journal-title":"CNS Drugs"},{"key":"10.1016\/j.phrs.2021.105682_bib208","first-page":"627","article-title":"Cost-effectiveness of brexanolone versus selective serotonin reuptakeinhibitors for the treatment of postpartum depression in the United States","volume":"26","author":"Eldar-Lissai","year":"2020","journal-title":"J. Manag. Care Spec. Pharm."},{"key":"10.1016\/j.phrs.2021.105682_bib209","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/phar.2331","article-title":"Brexanolone for postpartum depression: clinical evidence and practical considerations","volume":"39","author":"Leader","year":"2019","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.phrs.2021.105682_bib210","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.3390\/ijms19061694","article-title":"TSPO: an evolutionarily conserved protein with elusive functions","volume":"19","author":"Bonsack","year":"2018","journal-title":"IJMS"},{"key":"10.1016\/j.phrs.2021.105682_bib211","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1073\/pnas.74.9.3805","article-title":"Specific benzodiazepine receptors in rat brain characterized by high-affinity (3H)diazepam binding","volume":"74","author":"Braestrup","year":"1977","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2021.105682_bib212","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1042\/BCJ20170648","article-title":"TSPO mutations in rats and a human polymorphism impair the rate of steroid synthesis","volume":"474","author":"Owen","year":"2017","journal-title":"Biochem. J."},{"key":"10.1016\/j.phrs.2021.105682_bib213","first-page":"402","article-title":"Over-expression of TSPO in the hippocampal CA1 area alleviates cognitive dysfunction caused by lipopolysaccharide in mice","volume":"2016","author":"Zhang","year":"1646","journal-title":"Brain Res."},{"key":"10.1016\/j.phrs.2021.105682_bib214","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.neuropharm.2017.06.023","article-title":"Overexpression of the 18 kDa translocator protein (TSPO) in the hippocampal dentate gyrus produced anxiolytic and antidepressant-like behavioural effects","volume":"125","author":"Li","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2021.105682_bib215","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.3389\/fphar.2018.01364","article-title":"The 18 kDa translocator protein (TSPO) overexpression in hippocampal dentate gyrus elicits anxiolytic-like effects in a mouse model of post-traumatic stress disorder","volume":"9","author":"Zhang","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phrs.2021.105682_bib216","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/hup.757","article-title":"Efficacy of etifoxine compared to lorazepam monotherapy in the treatment of patients with adjustment disorders with anxiety: a double-blind controlled study in general practice","volume":"21","author":"Nguyen","year":"2006","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.phrs.2021.105682_bib217","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.brainres.2007.09.041","article-title":"Neurosteroid allopregnanolone mediates anxiolytic effect of etifoxine in rats","volume":"1184","author":"Ugale","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.phrs.2021.105682_bib218","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.pbb.2005.11.013","article-title":"The anxiolytic etifoxine activates the peripheral benzodiazepine receptor and increases the neurosteroid levels in rat brain","volume":"82","author":"Verleye","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.phrs.2021.105682_bib219","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/sj.bjp.0705681","article-title":"Antianxiety and antidepressant-like effects of AC-5216, a novel mitochondrial benzodiazepine receptor ligand","volume":"142","author":"Kita","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2021.105682_bib220","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.pnpbp.2013.04.010","article-title":"Repeated administration of AC-5216, a ligand for the 18kDa translocator protein, improves behavioral deficits in a mouse model of post-traumatic stress disorder","volume":"45","author":"Qiu","year":"2013","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2021.105682_bib221","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.pbb.2007.12.006","article-title":"Involvement of neurosteroids in the anxiolytic-like effects of AC-5216 in mice","volume":"89","author":"Kita","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.phrs.2021.105682_bib222","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1177\/0269881115625115","article-title":"Involvement of allopregnanolone in the anti-PTSD-like effects of AC-5216","volume":"30","author":"Zhang","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.phrs.2021.105682_bib223","doi-asserted-by":"crossref","first-page":"37345","DOI":"10.1038\/srep37345","article-title":"The antidepressant-like activity of AC-5216, a ligand for 18KDa translocator protein (TSPO), in an animal model of diabetes mellitus","volume":"6","author":"Qiu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2021.105682_bib224","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1365-2826.2011.02166.x","article-title":"Translocator protein (18 kDa) as a target for novel anxiolytics with a favourable side-effect profile","volume":"24","author":"Nothdurfter","year":"2012","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.phrs.2021.105682_bib225","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.pnpbp.2009.05.018","article-title":"Lack of tolerance to anxiolysis and withdrawal symptoms in mice repeatedly treated with AC-5216, a selective TSPO ligand","volume":"33","author":"Kita","year":"2009","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2021.105682_bib226","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1126\/science.1175055","article-title":"Translocator protein (18 kD) as target for anxiolytics without benzodiazepine-like side effects","volume":"325","author":"Rupprecht","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.phrs.2021.105682_bib227","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12990-015-0013-6","article-title":"Anxiolytic-like effects of translocator protein (TSPO) ligand ZBD-2 in an animal model of chronic pain","volume":"11","author":"Wang","year":"2015","journal-title":"Mol. Pain"},{"key":"10.1016\/j.phrs.2021.105682_bib228","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s12017-016-8425-7","article-title":"Antidepressant-like and anxiolytic-like effects of ZBD-2, a novel ligand for the translocator protein (18kDa)","volume":"19","author":"Wang","year":"2017","journal-title":"Neuromol. Med."},{"key":"10.1016\/j.phrs.2021.105682_bib229","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.neuropharm.2013.09.016","article-title":"Antidepressant-like and anxiolytic-like effects of YL-IPA08, a potent ligand for the translocator protein (18kDa)","volume":"81","author":"Zhang","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2021.105682_bib230","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1017\/S1461145714000479","article-title":"Anxiolytic-like effects of YL-IPA08, a potent ligand for the translocator protein (18 kDa) in animal models of post-traumatic stress disorder","volume":"17","author":"Zhang","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.phrs.2021.105682_bib231","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13041-018-0355-x","article-title":"Antidepressant-like effects of translocator protein (18kDa) ligand ZBD-2 in mouse models of postpartum depression","volume":"11","author":"Li","year":"2018","journal-title":"Mol. Brain"},{"key":"10.1016\/j.phrs.2021.105682_bib232","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1007\/s11064-020-03036-9","article-title":"Anxiolytic and anti-depressive like effects of translocator protein (18 kDa) ligand YL-IPA08 in a rat model of postpartum depression","volume":"45","author":"Ren","year":"2020","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.phrs.2021.105682_bib233","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1134\/S1607672915050063","article-title":"The first dipeptide ligand of translocator protein: design and anxiolytic activity","volume":"464","author":"Gudasheva","year":"2015","journal-title":"Dokl. Biochem. Biophys."},{"key":"10.1016\/j.phrs.2021.105682_bib234","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2174\/1573406415666181119164846","article-title":"Design, synthesis and anxiolytic activity evaluation of N-acyltryptophanyl- containing dipeptides, potential TSPO ligands","volume":"15","author":"Gudasheva","year":"2019","journal-title":"Med. Chem."},{"key":"10.1016\/j.phrs.2021.105682_bib235","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1134\/S1607672916040165","article-title":"Dependence of anxiolytic effects of the dipeptide TSPO ligand GD-23 on neurosteroid biosynthesis","volume":"469","author":"Gudasheva","year":"2016","journal-title":"Dokl. Biochem. Biophys."},{"key":"10.1016\/j.phrs.2021.105682_bib236","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/epi.13705","article-title":"Randomized, double-blind, placebo-controlled phase 2 study of ganaxolone as add-on therapy in adults with uncontrolled partial-onset seizures","volume":"58","author":"Sperling","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.phrs.2021.105682_bib237","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3389\/fncel.2014.00256","article-title":"Ganaxolone improves behavioral deficits in a mouse model of post-traumatic stress disorder","volume":"8","author":"Pinna","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.phrs.2021.105682_bib238","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1007\/s00213-017-4649-y","article-title":"A randomized controlled trial of ganaxolone in posttraumatic stress disorder","volume":"234","author":"Rasmusson","year":"2017","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.phrs.2021.105682_bib239","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.19m12887","article-title":"Effects of open-label, adjunctive ganaxolone on persistent depression despite adequate antidepressant treatment in postmenopausal women: a pilot study","volume":"81","author":"Dichtel","year":"2020","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.phrs.2021.105682_bib240","doi-asserted-by":"crossref","first-page":"7810","DOI":"10.1021\/acs.jmedchem.7b00846","article-title":"Neuroactive steroids. 2.3 alpha-Hydroxy-3 beta-methyl-21-(4-cyano-1H-pyrazol-1 \u2019-yl)-19-nor-5 beta-pregnan-20-one (SAGE-217): a clinical next generation neuroactive steroid positive allosteric modulator of the (gamma-aminobutyric acid)(A) receptor","volume":"60","author":"Botella","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.phrs.2021.105682_bib241","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108333","article-title":"Preclinical characterization of zuranolone (SAGE-217), a selective neuroactive steroid GABAA receptor positive allosteric modulator","volume":"181","author":"Althaus","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2021.105682_bib242","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s40262-019-00801-0","article-title":"SAGE-217, a novel GABAA receptor positive allosteric modulator: clinical pharmacology and tolerability in randomized phase I dose-finding studies","volume":"59","author":"Hoffmann","year":"2020","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.phrs.2021.105682_bib243","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1056\/NEJMoa1815981","article-title":"Trial of SAGE-217 in patients with major depressive disorder","volume":"381","author":"Gunduz-Bruce","year":"2019","journal-title":"N. Engl. J. Med."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661821002668?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661821002668?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:31:22Z","timestamp":1760913082000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661821002668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":243,"alternative-id":["S1043661821002668"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2021.105682","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Allopregnanolone in mood disorders: Mechanism and therapeutic development","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2021.105682","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105682"}}